{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["19(1)"],"submitter":["Kawamura Y"],"pubmed_abstract":["<h4>Objective</h4>Endovascular treatment of wide-neck cerebral aneurysms with conventional coiling alone remains challenging. Stent-assisted coiling using a vascular reconstruction device offers an alternative strategy. This study evaluated the safety and effectiveness of the Enterprise Vascular Reconstruction Device (Cerenovus, Irvine, CA, USA) in patients with wide-neck cerebral aneurysms.<h4>Methods</h4>Post-marketing surveillance records were collected for all Enterprise stent usage using case report forms at 30 days and at 1, 2, and 3 years post-procedure. A total of 738 cases, including 411 on-label cases, were analyzed across 83 hospitals.<h4>Results</h4>Stent deployment was successful in 98.8% of cases, and the overall procedure success rate was 93.9% immediately post-procedure. Th"],"journal":["Journal of neuroendovascular therapy"],"pagination":["2025-0063"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12530950"],"repository":["biostudies-literature"],"pubmed_title":["Vascular Reconstruction Device for Coil Embolization of Wide-Neck Type Cerebral Aneurysm: Findings from a Post-Marketing Surveillance Study in Japan."],"pmcid":["PMC12530950"],"pubmed_authors":["Kawamura Y","Honda A","Taki W","Sakai C","Ito Y","Kuwayama N","Imamura H","Hyodo A","Izumi T","Matsumaru Y","Miyachi S","Sakai N"],"additional_accession":[]},"is_claimable":false,"name":"Vascular Reconstruction Device for Coil Embolization of Wide-Neck Type Cerebral Aneurysm: Findings from a Post-Marketing Surveillance Study in Japan.","description":"<h4>Objective</h4>Endovascular treatment of wide-neck cerebral aneurysms with conventional coiling alone remains challenging. Stent-assisted coiling using a vascular reconstruction device offers an alternative strategy. This study evaluated the safety and effectiveness of the Enterprise Vascular Reconstruction Device (Cerenovus, Irvine, CA, USA) in patients with wide-neck cerebral aneurysms.<h4>Methods</h4>Post-marketing surveillance records were collected for all Enterprise stent usage using case report forms at 30 days and at 1, 2, and 3 years post-procedure. A total of 738 cases, including 411 on-label cases, were analyzed across 83 hospitals.<h4>Results</h4>Stent deployment was successful in 98.8% of cases, and the overall procedure success rate was 93.9% immediately post-procedure. Th","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-06-04T14:29:32.201Z","creation":"2026-05-10T03:11:26.024Z"},"accession":"S-EPMC12530950","cross_references":{"pubmed":["41112966"],"doi":["10.5797/jnet.oa.2025-0063"]}}